Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

The FDA has approved the second GLP-1 pill for overweight and obesity. How does it compare to the Wegovy oral pill?

Experts from AMCP discuss the real-world evidence on GLP-1 usage and health care spending. In this Q&A, Urick discusses the ...

News and commentary from the endocrinology world ...

BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has successfully completed production of its largest ...

When it comes to body weight, overall dietary intake matters more than specific timing. People who follow high-fiber diets ...

Early prescription volume signals uptake for an oral anti-obesity entrant, but competitive positioning versus oral ...

Snoring isn’t just keeping you or your partner awake—it could also be eroding your intimacy. Here’s what you can do about it.

Portfolio strategy emphasizes disciplined profit-taking in volatile markets, maintaining significant dry powder (currently 42 ...

Despite headwinds, the U.S. life sciences industry continues to yield impressive results, leveraging technology for earlier ...

Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases April 20, 2026 8:30 AM ...

Anhedonia, the clinical term for “Ozempic personality," is described by those who experience it as a general flattening of ...